Annual Current Liabilities
$102.21 M
+$24.23 M+31.07%
December 31, 2024
Summary
- As of March 12, 2025, DNLI annual total current liabilities is $102.21 million, with the most recent change of +$24.23 million (+31.07%) on December 31, 2024.
- During the last 3 years, DNLI annual current liabilities has fallen by -$276.04 million (-72.98%).
- DNLI annual current liabilities is now -72.98% below its all-time high of $378.25 million, reached on December 31, 2021.
Performance
DNLI Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$102.21 M
+$15.12 M+17.36%
December 31, 2024
Summary
- As of March 12, 2025, DNLI quarterly total current liabilities is $102.21 million, with the most recent change of +$15.12 million (+17.36%) on December 31, 2024.
- Over the past year, DNLI quarterly current liabilities has stayed the same.
- DNLI quarterly current liabilities is now -73.87% below its all-time high of $391.08 million, reached on March 31, 2023.
Performance
DNLI Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
DNLI Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +31.1% | 0.0% |
| 3 y3 years | -73.0% | -71.9% |
| 5 y5 years | +125.4% | -71.9% |
DNLI Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -73.0% | +31.1% | -73.9% | +47.4% |
| 5 y | 5-year | -73.0% | +125.4% | -73.9% | +125.4% |
| alltime | all time | -73.0% | +2836.2% | -73.9% | +1022.4% |
Denali Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $102.21 M(+31.1%) | $102.21 M(+17.4%) |
| Sep 2024 | - | $87.09 M(+16.9%) |
| Jun 2024 | - | $74.53 M(-9.7%) |
| Mar 2024 | - | $82.58 M(+5.9%) |
| Dec 2023 | $77.98 M(-78.6%) | $77.98 M(+9.6%) |
| Sep 2023 | - | $71.18 M(+2.6%) |
| Jun 2023 | - | $69.36 M(-82.3%) |
| Mar 2023 | - | $391.08 M(+7.5%) |
| Dec 2022 | $363.92 M(-3.8%) | $363.92 M(+0.9%) |
| Sep 2022 | - | $360.67 M(+3.6%) |
| Jun 2022 | - | $348.16 M(+2.0%) |
| Mar 2022 | - | $341.24 M(-9.8%) |
| Dec 2021 | $378.25 M(+427.5%) | $378.25 M(+597.2%) |
| Sep 2021 | - | $54.25 M(+5.5%) |
| Jun 2021 | - | $51.41 M(-5.9%) |
| Mar 2021 | - | $54.61 M(-23.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | $71.70 M(+58.1%) | $71.70 M(-32.0%) |
| Sep 2020 | - | $105.41 M(+80.3%) |
| Jun 2020 | - | $58.46 M(+22.7%) |
| Mar 2020 | - | $47.63 M(+5.1%) |
| Dec 2019 | $45.34 M(+38.3%) | $45.34 M(-2.9%) |
| Sep 2019 | - | $46.69 M(+0.3%) |
| Jun 2019 | - | $46.55 M(+7.6%) |
| Mar 2019 | - | $43.24 M(+31.9%) |
| Dec 2018 | $32.79 M(+131.5%) | $32.79 M(+3.7%) |
| Sep 2018 | - | $31.62 M(+2.0%) |
| Jun 2018 | - | $31.01 M(+80.6%) |
| Mar 2018 | - | $17.17 M(+21.2%) |
| Dec 2017 | $14.16 M(+55.5%) | $14.16 M(+39.5%) |
| Sep 2017 | - | $10.15 M(+11.5%) |
| Dec 2016 | $9.11 M(+161.6%) | $9.11 M |
| Dec 2015 | $3.48 M | - |
FAQ
- What is Denali Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Denali Therapeutics?
- What is Denali Therapeutics annual current liabilities year-on-year change?
- What is Denali Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Denali Therapeutics?
- What is Denali Therapeutics quarterly current liabilities year-on-year change?
What is Denali Therapeutics annual total current liabilities?
The current annual current liabilities of DNLI is $102.21 M
What is the all time high annual current liabilities for Denali Therapeutics?
Denali Therapeutics all-time high annual total current liabilities is $378.25 M
What is Denali Therapeutics annual current liabilities year-on-year change?
Over the past year, DNLI annual total current liabilities has changed by +$24.23 M (+31.07%)
What is Denali Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of DNLI is $102.21 M
What is the all time high quarterly current liabilities for Denali Therapeutics?
Denali Therapeutics all-time high quarterly total current liabilities is $391.08 M
What is Denali Therapeutics quarterly current liabilities year-on-year change?
Over the past year, DNLI quarterly total current liabilities has changed by $0.00 (0.00%)